Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of End-tidal CO2 for Transplumonary Blood Flow Monitoring During PVA-ECMO

NCT03323268 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03323268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03323268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of End-tidal CO2 for Transplumonary Blood Flow Monitoring During PVA-ECMO
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
January 12, 2016
Completion date
October 23, 2017
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

residual cardiac output during pva-ecmo